With precision medicine as an investment theme and global R&D level as a benchmark, we aim to deliver the emerging market demand in China by focusing on Biotechnology, New Drug R&D, Emerging Medical Service and Advanced Medical Devices. We primarily focus on early- to mid stage projects, but also consider other stages. SC manages three healthcare funds and covers more than 80 projects.
We aim for a fine blueprint of lifestyle for the next generation of consumers, by searching for the business model and product innovation from the up, middle and down stream of the industry. SC manages three consumer-driven innovation funds and covers more than 70 projects.
We pay close attention to the technological breakthroughs of China's leading scientific research team, and mainly focus on AI and Big Data, Advanced Manufacturing, the New Generation of IT and New Materials. We give priority to projects headquartered in the Greater Bay Area with Shenzhen as a center. SC manages one hardcore technology angel fund and covers more than 10 projects.